Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Editorial

Subarachnoid Hemorrhage

Author(s): Theodosis Kalamatianos

Volume 23, Issue 11, 2024

Published on: 07 June, 2024

Page: [1295 - 1296] Pages: 2

DOI: 10.2174/187152732311240607222910

conference banner
Next »
[1]
Etminan N, Chang HS, Hackenberg K, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population. JAMA Neurol 2019; 76(5): 588-97.
[http://dx.doi.org/10.1001/jamaneurol.2019.0006] [PMID: 30659573]
[2]
Ikram A, Javaid MA, Ortega-Gutierrez S, et al. Delayed cerebral ischemia after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2021; 30(11): 106064.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.106064] [PMID: 34464924]
[3]
Thilak S, Brown P, Whitehouse T, et al. Diagnosis and management of subarachnoid haemorrhage. Nat Commun 2024; 15(1): 1850.
[http://dx.doi.org/10.1038/s41467-024-46015-2] [PMID: 38424037]
[4]
Adamou A, Alektoroff K, Politi M, Alexandrou M, Roth C, Papanagiotou P. Flow diversion for the management of posterior circulation’s intracranial aneurysms. CNS Neurol Disord Drug Targets 2024; 23(11): 1297-302.
[http://dx.doi.org/10.2174/1871527322666230626110934] [PMID: 37365790]
[5]
Mavridis I, Pyrgelis ES, Agapiou E, Assi J. Vasospasm in pediatric subarachnoid hemorrhage. CNS Neurol Disord Drug Targets 2024; 23(11): 1303-7.
[http://dx.doi.org/10.2174/0118715273274147231104160152] [PMID: 38013445]
[6]
Apostolakis S, Stavrinou P. Pharmacotherapy in SAH: Clinical trial lessons. CNS Neurol Disord Drug Targets 2024; 23(11): 1308-19.
[http://dx.doi.org/10.2174/0118715273251761231127095039] [PMID: 38243987]
[7]
Skouras P, Kalamatianos T, Markouli M, Karagiannis A, Stavrinou LC. The landscape of randomized clinical trial meta-analyses on statins for aneurysmal subarachnoid hemorrhage: A scoping review. CNS Neurol Disord Drug Targets 2024; 23(11): 1320-7.
[http://dx.doi.org/10.2174/0118715273270503230928100141] [PMID: 37855296]
[8]
Psochias F, Mavrovounis G, Stranjalis G, Kalamatianos T. GFAP and UCHL1 in non-traumatic SAH: The story thus Far. A systematic review of the literature. CNS Neurol Disord Drug Targets 2024; 23(11): 1328-44.
[http://dx.doi.org/10.2174/0118715273276472231116104549] [PMID: 38213168]

© 2024 Bentham Science Publishers | Privacy Policy